Presentation: When Commercial Influence Comes Too Late: Managing Value Risk After Trial Design Decisions Are Made

Session details:

• Recognize how early trial design and evidence strategy structurally constrain future commercial outcomes
• Distinguish which value gaps can still be mitigated downstream and which become difficult to reverse
• Develop strategies to address limitations created by delayed commercial and market access involvement
• Embed commercial and access perspectives earlier into development governance and evidence planning